Answer
Yes, Pegasys (peginterferon alfa-2a) treatment was associated with clinically significant thyroid test abnormalities requiring medical intervention, observed in 4.9% of patients receiving Pegasys with ribavirin in study NV15801, a frequency similar to other interferons.
Sources for this answer
- Pegasys 90 micrograms, 135 micrograms and 180 micrograms solution for injection in pre-filled syringepharmaand GmbH · emc · SmPC §4.8 Undesirable effects · Version 2Document updated
Sources checked